A recently described new form of hyperphenylalaninemia is characterized by the excretion of 7-substituted isomers of biopterin and neopterin and 7-oxo-biopterin in the urine of patients. It has been shown that the 7-substituted isomers of biopterin and neopterin derive from L-tetrahydrobiopterin and D-tetrahydroneopterin and are formed during hydroxylation of phenylalanine to tyrosine with rat liver dehydratase-free phenylalanine hydroxylase.
was proven by gas-chromatography mass spectrometry. Tetrahydroneopterin and 6-hydroxymethyltetrahydropterin also are converted to their corresponding 7-substituted isomers and serve as cofactors in the phenylalanine hydroxylase reaction. Dihydroneopterin is converted by dihydrofolate reductase to the tetrahydro form which is biologically active as a cofactor for the aromatic amino acid monooxygenases. The 6-substituted pterin to 7-substituted pterin conversion occurs in the absence of pterin-4a-carbinolamine dehydratase and is shown to be a nonenzymatic process. 7-Tetrahydrobiopterin is both a substrate (cofactor) and a competitive inhibitor with 6-tetrahydrobiopterin (Ki z 8 pM) in the phenylalanine hydroxylase reaction. For the first time, the formation of 7-substituted pterins from their 6-substituted isomers has been demonstrated with tyrosine hydroxylase, another important mammalian enzyme which functions in the hydroxylation of phenylalanine and tyrosine. L-Tetrahydrobiopterin is the natural cofactor of pterindependent mammalian monooxygenases such as phenylalanine-4-hydroxylase [l], tyrosine-3-hydroxylase and tryptophan-5-hydroxylase [2, 31. The last two enzymes play a key role in the biosynthesis of the neurotransmitters dopamine, serotonin, epinephrine and norepinephrine [4] . The absence of phenylalanine hydroxylase activity leads to classical phenylketonuria (PKU) [5]. Two additional forms of PKU are known to be caused by enzyme defects involved in the de novo biosynthesis of L-tetrahydrobiopterin [6, 71, one by a defect in the pterin, 2-amino-4-oxopteridine; primapterin, 7-(~-erythro-l',2'-dihydroxypropy1)pterin; anapterin, 7 -(~-or L-erythro-l',2',3'-trihydroxypropy1)pterin; 4a-CA, 4a-hydroxy-5,6,7,8-tetrahydropterin; PKU, phenylketonuria; PCDH, pterin-4a-carbinolamine dehydratase (formerly designated phenylalanine hydroxylase stimulating factor, PHS), phenylalanine hydroxylase. Enzymes. Pterin-4a-carbinolamine dehydratase (EC 1.14.16.1); tyrosine hydroxylase (EC 1.14. 16 .2); tryptophan hydroxylase (EC 1.14.16.4); catalase (EC 1.11.1.6); dihydrofolate reductase (EC 1.5.1.3j; dihydroptcridine reductase (EC 1.6.99.7). regeneration of the cofactor [S]. These forms are referred to as 'atypical' PKU.
Another specific type of hyperphenylalaninemia has been discovered recently that is transient and characterized by the excretion of the 7-substituted pterins in the urine of patients [9 -111. After oral administration of L-tetrahydrobiopterin, the excretion of biopterin and 7-biopterin (primapterin) was found to increase, suggesting that these 7-substituted pterins derive from their respective 6-tetrahydro isomers [12, 131.
During the hydroxylation, L-tetrahydrobiopterin is converted to its 4a-carbinolamine. A dehydration of this intermediate species to a quinonoid dihydropterin is accomplished by pterin-4a-carbinolamine dehydratase (PCDH) [14] (see Scheme 1). In the absence of dehydratase activity, 4a-hydroxy-5,6,7,8-tetrahydrobiopterin (4a-CA) accumulates [14] . Ringopening and ring-closing reactions of this intermediate have been suggested by Bailey et al. [15] . Such decay and rearrangement mechanisms, leading to the formation of 7-substituted pterins via a spiro-intermediate, have recently been proposed by our group [16] and by Davis et al. [17] .
Here we provide direct, GC-MS, evidence for the structure of 7-biopterin formed in v i m and its assumed mechanism of formation. The in v i m investigations were extended for human phenylalanine hydroxylase and recombinant human tyrosine hydroxylase. We also give an explanation for the hyperphenylalaninemia of these primapterinuric patients.
MATERIALS AND METHODS

Materials
Pteridine standards were purchased from Dr B. Schircks Laboratory (Jona, Switzerland). 7-Hydroxymethylpterin, as reference compound, was synthesized by our group. Dehydrdtase-free rat liver phenylalaninc hydroxylase was purified according to the method of Shiman [ 181, followed by two further purification steps; ion-exchange chromatography (10 ml DEAE Toyopearl 650 M) and gel filtration (Sephacryl S-200 HR, column; 1.6 cm x 100 cm). Human phenylalanine hydroxylase was purified according to the method of Petruschka et al. [I91 with the same two additional purification steps as for the rat enzyme. Human tyrosine hydroxylase isoenzyme 1 was expressed in Escherichia coli and purified to homogeneity as described recently [20, 211 . The tyrosine hydroxylase expression vector was constructed by Drs €3. Le Bourdelles and J. Mallet (Lab. de Neurobiologie Cellulaire et Moleculaire, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France). Catalase, NADPH and NADH were obtained from Boehringer (Mannheim, FRG), dihydrofolate reductase dihydropteridine reductase and bis(trimethy1-si1yl)trifluoroacetamide from Sigma (St Louis, USA), the ultrafree MC filter units with two different exclusion volumes (5000 and 10000 NMWL) from Millipore (Bedford, USA).
Methods
Chcm ical investigations
The reduced pterins were analyzed by HPLC [22] . The oxidized pterins were measured with the HPLC system tuned for blue-fluorescent compounds (excitation and emission wavelengths were 350 nm and 450 nm, respectively) [33] . For the separation of 7-hydroxymethylpterin from 6-hydroxymethylpterin, ion-exchange HPLC was used according to Dhondt et al. [24] but with only 1.75% methanol and 1.25% acetonitrile. The pterins were identified by their different retention times and by spiking the samples with reference compounds.
For GC-MS measurements of the primapterin formed in vitro, the assay mixture of the phenylalanine hydroxylase (see below) was scaled up to a total volume of 10 ml. The pterins were oxidized at pH 2 with MnO, and purified/isolated using ion-exchange chromatography (Dowex 50W x 8 and Dowex 1 x 4). The fluorescent fractions were collected, evaporated to dryness, and derivatized with bis(trimethylsily1)trifluoroacetamide/acetonitrile for 1 h at 100°C. For GC-MS conditions, see [25] .
Phenylalanine hydroxylase assay
The experiments with dehydratase-free rat liver phenylalanine hydroxylase were performed in 0.1 M TrisjHCl, pH 8.5, with 0.35 U enzyme (specific activity 8.5 U/mg protein), 1 mM L-phenylalanine and with 1 mg/ ml catalase and 0.1 mg/ml dihydropterin reductase, 5 mM NADH, 30 pM L-tetrahydrobiopterine [I61 or 6-hydroxymethyltetrahydropterin. Experiments with human phenylalanine hydroxylase were performed similarly. Pterin analysis was carried out by HPLC and fluorescence detection [23] . Amino acid analysis of, e. g. L-phenylalanine and L-tyrosine, was performed with cationexchange chromatography and the ninhydrin reaction [26] .
Tyrosine hydroxylase assay
The experiments with the recombinant human tyrosine hydroxylase isoenzyme 1 were carried out in 0.1 M Tris/HCl, pH 8.25, 0.5 mg/ml tyrosine hydroxylase, 1 mM phenylalanine with 1 mg/ ml catalase and 0.1 mg/ml dihydropteridine reductase, 5 mM NADH, and 50 pM L-tetrahydrobiopteridin. Pterins were measured by HPLC and fluorescence detection [23] . Amino acids, e. g. L-phenylalanine, t-tyrosine and ~-3 , 4 -dihydroxyphenylalanine, were analyzed according to Stein and Moore [26] .
Dihydropteridine reductase assay
The dihydropteridine reductase assay mixture contained 50 mM Tris/HCl, pH 7.2, 0.9 mM H,O,, 8 pg peroxidase, 3.2 mU dihydropteridine reductase (specific activity 55 U/ mg protein), 10 pM 6,7-dimethyltetrahydropterin and 100 pM NADH to start the reaction. The reaction was monitored spectrophotometrically at 340 nm [27] .
Dihydrofolate reductase assay
For the incubation experiments of 7,8-dihydro-~-neopterin with dihydrofolate reductase, the following assay mixture was used: 0.1 M potassium phosphate, pH 7.4, 1 mM NADPH, 10 mM 1,4-dithioerythritol, 40 pM 7,8-dihydro-~-neopterin and an excess of dihydrofolate reductase. The mixture was incubated for 30 min at 37°C. The assay mixture for the reduced pterins was injected directly into the HPLC system equipped with an electrochemical detector.
Kinetics
The time dependence of the ratio of tyrosine to primapterin formation in vitro was studied by taking aliquots from the reaction mixture, followed by oxidation after varying periods of time (0 -2.5 h). The same procedure was followed for human tyrosine hydroxylase. In this case, however, the time dependence of formation of tyrosine and 3,4-dihydroxyphenylalanine was determined compared to primapterin. The pterins were analyzed by HPLC and fluorescence detection and tyrosine and 3,4-dihydroxyphenylalanine with cation-exchange chromatography and the ninhydrin reaction. Inhibition experiments for the phenylalanine hydroxylase reaction were performed with L-tetrahydrobiopterin (concentrations 5 -20 pM) as substrate and L-7-tetrahydrobiopterin (concentrations 2 -30 pM) as potential inhibitor.
For the parallel detection of the 4a-carbinolamine (ultraviolet absorption at 245 nm) and the quinonoid product (ultraviolet absorption at 334 nm), the incubation experiments were performed according to Lazarus et al. [14] . For the assays at pH 6.8, a 100-mM potassium phosphate buffer was used. In some experiments, the proteins were removed from the incubation mixture by ultrafiltration after 1.5 min incubation (maximum for 4a-carbinolamine formation).
RESULTS
Identification and structure of the new pterins
In vitro incubation of 6-tetrahydrobiopterin and 6-hydroxymethyltetrahydropterin demonstrated the formation of varying amounts of the corresponding 7-substituted pterins (Fig. 1) .
When analysis was carried out after a short time of incubation, 5% of the L-tetrahydrobiopterin was rearranged to Lprimapterin (data not shown). However, when the sample was left at room temperature for a longer period of time, the ratio of the pterins changed drastically. During incubation, the amount of L-biopterin decreased. We confirmed that the amount of L-primapterin formed remained constant after about 90 min, as had also been shown by Davis et al. [17] . The identity of primapterin was confirmed by GC-MS, as shown in Fig. 2 . The insert shows that under GC conditions, the silyl derivatives of the two isomers are clearly separated. The mass spectra obtained from the two peaks were essentially identical, as expected for such isomers. These results were confirmed using authentic 7-substituted and 6-substituted biopterins. The fragmentation pattern obtained from isolated L-primapterin (Fig. 2) confirms the presence of an isomer of L-biopterin [25] as deduced from their identical fragmentation patterns.
Effect of pterinda-carbinolamine dehydratase on 7-pterin formation
In an extension of previous experiments which involved the use of dehydratase-free phenylalanine hydroxylase I161 and rat pterin-4a-carbinolamine (PCDH), we found that human PCDH had the same effect on 7-substituted pterin formation (data not shown) as the rat enzyme. To obtain information on the effect of dehydratase on various intermediates during the phenylalanine hydroxylase reaction, we monitored the time-dependent formation of 4a-CA and of quinonoid 6-methyldihydropterin by ultraviolet spectroscopy (Fig. 3) . As expected, no significant formation of quinonoid-6-methyldihydropterin was detected in the absence of dehydratase. Increasing amounts of PCDH enhanced formation of the quinonoid species, with no effect on the formation of the 4a-CA itself.
The ratio of primapterin to tyrosine formation was addressed by comparing the corresponding velocities, as shown in Fig. 4a . Due to the small amounts of product formed, the parameters for 7-substituted pterin formation obtained at incubation times shorter than 1 h were not reliable. Low concentrations of 7-substituted pterins appear as a shoulder on the chromatograms of 6-substituted pterins. At longer incubation times, the quotient of tyrosine/primapterin is quite constant; it has a value of z 600, indicating that 1 mol 7-substituted pterin is formed for about 600 turnover events leading to tyrosine production (Fig. 4a) . Analogous experiments were carried out with tyrosine hydroxylase. In this case, phenylalanine was used as substrate that is converted enzymatically to tyrosine and 3,4-dihydroxyphenylalanine. The hydroxylation of phenylalanine by tyrosine-3-monooxygenase has already been reported by Ikeda et al. [28] , Shiman et al. [29] and Fukami et al. [30] . The ratio of formation of tyrosine plus 3,4-dihydroxyphenylalanine compared to primapterin is approximately 1000 (Fig. 4b) .
The effect of phenylalanine hydroxylase and dihydropteridine reductase, and possibly of catalase, on the reactions of pterin-4a-carbinolamine was studied by following the fate of the latter upon separation by ultrafiltration, as detailed in the experimental section. An incubation time of 1.5 min was selected, since at this time a good quantity of 4a-CA is formed [I41 while primapterin is not yet detectable. After leaving the obtained filtrate at room temperature over 2-16 h, the pterins were investigated by HPLC. With and without filtration, the same quantity of 7-biopterin was formed. Therefore, we conclude that the quantity of 7-substituted pterin is not dependent on the presence of protein.
A further important parameter affecting the formation of 7-substituted pterins is the pH. Its influence on the stability of the intermediates of the hydroxylase reaction can be followed by monitoring the absorbance of 4a-hydroxy-6-dihydroxymethyltetrahydropterin and that of quinonoid 6-methyldihydropterin. Thus, at pH 8.5, only very little of the quinonoid product is formed, while at neutral pH the rate of carbinolamine decay is higher and consequently more quinonoid 6-methyldihydropterin is formed.
Formation of tetrahydroneopterin
The detection of 7-neopterin in the urine of patients and controls raises the question as to whether dihydroneopterin can be reduced in vivo to its tetrahydroform by dihydrofolate reductase and subsequently can act as cofactor of the pteridine-dependent hydroxylases. Upon incubation experiments in vitro of D-tetrahydroneopterin with dihydrofolate reductase and NADPH at pH 7.4, we demonstrated formation of D-dihydroneopterin (see Materials and Methods) and the possibility of its acting as substrate for the aromatic amino acid hydroxylases. The amount of tetrahydroneopterin formed was only 50% of the expected theoretical yield. In the HPLC chromatogram, two peaks were Found, one of D-tetrahydroneopterin and the other corresponding to tetrahydropterin (data not shown). An explanation for this observation is that D-tetrahydroneopterin easily splits off its side chain to form tetrahydropterin [31] .
Inhibition studies
In a previous communication [13] , we reported that L-7-tetrahydrobiopterin does not inhibit the phenylalanine hydroxylase reaction when the natural cofactor 6-tetrahydrobiopterin is used and that it is itself a cosubstrate. We have reinvestigated this aspect and the results depicted in Fig. 5 clearly indicate that 7-tetrahydrobiopterin competes with 6-tetrahydrobiopterin for the active site. This corresponds to our expectations. The Ki value of 8 pM obtained for 7-Ltetrahydrobiopterin compares to K, values of 20 pM and 1.5 pM, respectively, for 7-tetrahydrobiopterin and 6-tetrahydrobiopterin as substrates. In contrast, no apparent inhibition of dihydropteridine reductase was found (data not shown).
While this manuscript was under review, a manuscript by Davis et al. [32] was published showing that, due to the uncoupling of the phenylalanine hydroxylase reaction, 7-tetrahydrobiopterin is a poorer cofactor than 6-tetrahydrobiopterin.
DISCUSSION
The HPLC and GC-MS data obtained for 7-pterin isomers formed in vitro give conclusive evidence for the proposed structures. In previous reports [16, 171, the structure analysis was relying on comparison of properties such as HPLC retention times. Here we present evidence for the 7-substituted pterin structure based on the GC retention time, the molecular-ion and the fragmentation patterns, which are all identical with chemically synthesized primapterin. HPLC evidence in connection with thermospray mass spectrometry has been pointed out by Davis et al. [17] . This method is based on the ionization of a compound contained in the effluent from a liquid-chromatography column. These data were confirmed by our GC-MS investigations, which rely on the use of trimethylsilyl derivatives and on a different separation system and which thus yield supplementary information.
Experiments in which low-molecular-mass products were separated upon formation from the enzymes, show that the new pterins must originate from an intermediate formed during the phenylalanine hydroxylase reaction. We found that the quantity of 7-substituted pterins formed is independent of the presence of proteins.
We thus propose the sequence of reactions depicted in our scheme for the formation of 7-pterins from 6-pterins. In this scheme, the upper part represents the events which are part of the phenylalanine hydroxylase reaction cycle. The lower part summarizes the chemical events occurring when carbinolamine (A) can accumulate, e. g. in the absence of dehydratase.
It should be emphasized that the intermediates (B) and (D) as well as the carbinolamines (A) and (E) are structurally similar, with the exception of the position of the substituent R. The conversion of (E) to the 7-substituted quinonoid pterin (F), to dihydroprimapterin, and the reduction to 7-tetrahydrobiopterin are envisaged as occurring similarly as in the case of the 6-substituted isomers. Some chemical details and possible properties of these chemical intermediates have been discussed elsewhere [ 
161.
For primapterinuria, an atypical form of PKU, our results clearly point to an enzyme defect involving the absence of pterin-4a-carbinolamine dehydratase activity. Whether the enzyme itself is defective or whether protein expression or stability are impaired will have to be decided by further experiments involving direct measurements of PCDH activities and occurrence. Although it is difficult to explain the occurrence of a transient hyperphenylalaninemia in these PKU patients in the early stage of life, one can hypothesize that 7-tetrahydrobiopterin and other pterins temporarily play roles as cofactors and that the need for such cofactors varies at different stages of development.
While investigating whether 7-iso-neopterin may be formed by the same mechanism as that postulated for 7-isobiopterin, we showed that dihydrofolate reductase is able to reduce dihydroneopterin to its tetrahydroform.
The fact that 6-hydroxymethyltetrahydropterin, like Ltetrahydrobiopterin and D-tetrahydroneopterin [16] and
